Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

PTGX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,678,327.76

Protagonist Therapeutics Insider Trading History Chart

Protagonist Therapeutics Share Price & Price History

^$25.15

▲ +0.49 (1.99%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Protagonist Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/18/2024	Asif Ali	CFO	Sell	1,234	$25.11	$30,985.74	37,163
4/1/2024	Dinsesh V. Patel	CEO	Sell	25,000	$28.31	$707,750.00	549,590
3/1/2024	Asif Ali	CFO	Sell	14,248	$32.24	$459,355.52	38,397
3/1/2024	Dinsesh V. Patel	CEO	Sell	30,000	$31.62	$948,600.00	574,590
3/1/2024	William D Waddill	Director	Sell	12,975	$31.34	$406,636.50	12,000
1/9/2024	Suneel Gupta	Insider	Sell	5,000	$25.00	$125,000.00	187,567
12/21/2021	Dinsesh V. Patel	CEO	Sell	15,000	$32.14	$482,100.00
8/17/2021	David Y. Liu	Insider	Sell	14,779	$47.56	$702,889.24

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

98.63% of Protagonist Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protagonist Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Allspring Global Investments Holdings LLC	1,970	$57K	0.0%	-22.2%	0.003%
4/17/2024	Hennion & Walsh Asset Management Inc.	34,895	$1.01M	0.1%	+2.5%	0.060%
4/5/2024	Los Angeles Capital Management LLC	30,827	$0.89M	0.0%	+236.8%	0.053%
2/26/2024	Perceptive Advisors LLC	383,260	$8.79M	0.2%	-63.6%	0.664%
2/20/2024	Readystate Asset Management LP	57,206	$1.31M	0.0%	-69.0%	0.098%
2/15/2024	Opaleye Management Inc.	112,700	$2.58M	0.7%	N/A	0.195%
2/15/2024	Birchview Capital LP	48,000	$1.10M	0.9%	+26.3%	0.083%
2/14/2024	ADAR1 Capital Management LLC	200,859	$4.61M	1.6%	N/A	0.348%
2/14/2024	Superstring Capital Management LP	379,143	$8.69M	6.2%	N/A	0.657%
2/14/2024	Kynam Capital Management LP	2,004,875	$45.97M	5.1%	+10.2%	3.476%
2/14/2024	RTW Investments LP	5,315,514	$121.89M	1.9%	-1.8%	9.216%
2/13/2024	Rafferty Asset Management LLC	167,795	$3.85M	0.0%	-52.1%	0.291%
2/12/2024	Hsbc Holdings PLC	119,334	$2.74M	0.0%	-78.5%	0.207%
2/8/2024	Great Lakes Advisors LLC	91,153	$2.09M	0.0%	-35.6%	0.158%
2/7/2024	Gratus Capital LLC	397,571	$9.12M	0.5%	+35.8%	0.689%
2/7/2024	Principal Financial Group Inc.	14,429	$0.33M	0.0%	-3.6%	0.025%
2/7/2024	BNP Paribas Financial Markets	71,898	$1.65M	0.0%	-50.1%	0.125%
2/7/2024	Teacher Retirement System of Texas	10,640	$0.24M	0.0%	-17.9%	0.018%
2/7/2024	E Fund Management Co. Ltd.	8,957	$0.21M	0.0%	-50.2%	0.016%
2/6/2024	Charles Schwab Investment Management Inc.	455,321	$10.44M	0.0%	+3.7%	0.789%
2/6/2024	Los Angeles Capital Management LLC	9,154	$0.21M	0.0%	N/A	0.016%
2/6/2024	Swiss National Bank	90,700	$2.08M	0.0%	-9.8%	0.157%
1/31/2024	Obermeyer Wood Investment Counsel Lllp	12,066	$0.28M	0.0%	-12.5%	0.021%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,338	$0.24M	0.0%	+11.8%	0.018%
1/30/2024	Strs Ohio	2,400	$55K	0.0%	-80.0%	0.004%
1/26/2024	Moody Aldrich Partners LLC	62,327	$1.43M	0.3%	-9.6%	0.108%
1/25/2024	Allspring Global Investments Holdings LLC	2,533	$58K	0.0%	-70.2%	0.004%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	31,759	$0.73M	0.0%	-14.7%	0.055%
1/24/2024	China Universal Asset Management Co. Ltd.	6,675	$0.15M	0.0%	+353.2%	0.012%
12/18/2023	Vanguard Group Inc.	3,228,394	$53.85M	0.0%	+2.6%	5.597%
11/21/2023	Walleye Capital LLC	133,816	$2.23M	0.0%	+209.3%	0.232%
11/15/2023	Kennedy Capital Management LLC	319,534	$5.33M	0.1%	-20.8%	0.554%
11/15/2023	Kynam Capital Management LP	1,818,657	$30.34M	5.0%	+86.5%	3.153%
11/15/2023	Adage Capital Partners GP L.L.C.	700,000	$11.68M	0.0%	-45.9%	1.214%
11/14/2023	683 Capital Management LLC	732,784	$12.22M	1.0%	-10.0%	1.270%
11/14/2023	Braidwell LP	1,109,150	$18.50M	0.6%	N/A	1.923%
11/14/2023	Schonfeld Strategic Advisors LLC	154,098	$2.57M	0.0%	N/A	0.267%
11/14/2023	Profund Advisors LLC	58,716	$0.98M	0.1%	+13.4%	0.102%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	139,494	$2.33M	0.0%	-14.6%	0.242%
11/13/2023	Algert Global LLC	72,830	$1.22M	0.1%	+167.5%	0.126%
11/13/2023	Federated Hermes Inc.	60,234	$1.01M	0.0%	+102.6%	0.104%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	88,000	$1.47M	0.0%	N/A	0.153%
11/13/2023	Hsbc Holdings PLC	554,305	$9.17M	0.0%	-1.1%	0.961%
11/13/2023	FMR LLC	509,242	$8.49M	0.0%	+0.4%	0.883%
11/13/2023	Rafferty Asset Management LLC	350,281	$5.84M	0.0%	+22.7%	0.607%
11/13/2023	E Fund Management Co. Ltd.	17,991	$0.30M	0.0%	+17.2%	0.031%
11/9/2023	Deutsche Bank AG	71,913	$1.20M	0.0%	-91.7%	0.125%
11/9/2023	Citigroup Inc.	147,828	$2.47M	0.0%	+37.5%	0.256%
11/8/2023	Campbell & CO Investment Adviser LLC	56,577	$0.94M	0.1%	+175.2%	0.098%
11/8/2023	State Board of Administration of Florida Retirement System	16,303	$0.27M	0.0%	+5.9%	0.028%
11/8/2023	Obermeyer Wood Investment Counsel Lllp	13,792	$0.23M	0.0%	+9.4%	0.024%
11/8/2023	Charles Schwab Investment Management Inc.	439,102	$7.32M	0.0%	+4.6%	0.763%
11/8/2023	Swiss National Bank	100,600	$1.68M	0.0%	+2.7%	0.175%
11/8/2023	Moody Aldrich Partners LLC	68,968	$1.15M	0.2%	+64.8%	0.120%
11/7/2023	Great Lakes Advisors LLC	141,559	$2.36M	0.0%	-3.7%	0.246%
11/7/2023	Barclays PLC	176,837	$2.95M	0.0%	-8.6%	0.307%
11/7/2023	Jump Financial LLC	35,438	$0.59M	0.0%	+146.6%	0.062%
11/2/2023	Principal Financial Group Inc.	14,971	$0.25M	0.0%	+7.7%	0.026%
10/31/2023	Teacher Retirement System of Texas	12,954	$0.22M	0.0%	+6.1%	0.023%
10/31/2023	China Universal Asset Management Co. Ltd.	1,473	$25K	0.0%	+96.4%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	31,666	$0.53M	0.0%	+89.5%	0.055%
10/27/2023	Allspring Global Investments Holdings LLC	8,506	$0.14M	0.0%	-95.2%	0.015%
10/27/2023	TD Asset Management Inc	110,800	$1.85M	0.0%	+100.0%	0.193%
10/26/2023	Gratus Capital LLC	292,869	$4.89M	0.3%	+33.4%	0.509%
10/26/2023	Inspire Investing LLC	18,610	$0.31M	0.0%	N/A	0.032%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	37,222	$0.62M	0.0%	+4.4%	0.065%
10/26/2023	Strs Ohio	12,000	$0.20M	0.0%	-49.4%	0.021%
10/24/2023	Bank of New York Mellon Corp	201,444	$3.36M	0.0%	+0.9%	0.350%
10/19/2023	Simplicity Solutions LLC	10,411	$0.17M	0.0%	N/A	0.018%
8/24/2023	Perceptive Advisors LLC	1,469,761	$40.60M	1.2%	+52.3%	2.555%
8/15/2023	Readystate Asset Management LP	204,880	$5.66M	0.4%	N/A	0.356%
8/15/2023	Silverarc Capital Management LLC	25,000	$0.69M	0.2%	-76.3%	0.043%
8/15/2023	Suvretta Capital Management LLC	81,143	$2.24M	0.1%	N/A	0.141%
8/15/2023	HighVista Strategies LLC	29,179	$0.81M	0.4%	N/A	0.051%
8/15/2023	Kennedy Capital Management LLC	403,648	$11.15M	0.3%	+21.8%	0.702%
8/15/2023	Kynam Capital Management LP	975,298	$26.94M	3.7%	-29.1%	1.695%
8/14/2023	683 Capital Management LLC	814,000	$22.48M	1.6%	-6.8%	1.415%
8/14/2023	Cormorant Asset Management LP	1,500,000	$41.43M	2.3%	-11.8%	2.607%
8/14/2023	Artia Global Partners LP	112,340	$3.10M	1.1%	N/A	0.195%
8/14/2023	Jefferies Financial Group Inc.	760,561	$21.01M	0.2%	N/A	1.322%
8/14/2023	Ghisallo Capital Management LLC	50,000	$1.38M	0.2%	N/A	0.087%
8/14/2023	Silvercrest Asset Management Group LLC	128,197	$3.54M	0.0%	+13.1%	0.223%
8/11/2023	Harvest Investment Services LLC	44,113	$1.22M	0.7%	N/A	0.077%
8/11/2023	Campbell & CO Investment Adviser LLC	20,558	$0.57M	0.1%	N/A	0.036%
8/11/2023	Hsbc Holdings PLC	560,455	$15.65M	0.0%	N/A	0.974%
8/11/2023	Trexquant Investment LP	11,413	$0.32M	0.0%	N/A	0.020%
8/11/2023	Artal Group S.A.	500,000	$13.81M	0.4%	N/A	0.869%
8/11/2023	E Fund Management Co. Ltd.	15,354	$0.42M	0.0%	+76.2%	0.027%
8/11/2023	ExodusPoint Capital Management LP	14,654	$0.41M	0.0%	N/A	0.025%
8/10/2023	MetLife Investment Management LLC	28,596	$0.79M	0.0%	+19.6%	0.050%
8/10/2023	ProShare Advisors LLC	10,755	$0.30M	0.0%	+21.0%	0.019%
8/10/2023	Profund Advisors LLC	51,783	$1.43M	0.1%	+79.8%	0.090%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	35,667	$0.99M	0.0%	+29.1%	0.062%
8/10/2023	Great Lakes Advisors LLC	147,048	$4.06M	0.0%	-2.3%	0.256%
8/10/2023	Russell Investments Group Ltd.	43,522	$1.20M	0.0%	-56.5%	0.076%
8/10/2023	Citigroup Inc.	107,521	$2.97M	0.0%	-50.6%	0.187%
8/9/2023	Dimensional Fund Advisors LP	1,039,105	$28.70M	0.0%	-17.7%	1.806%
8/9/2023	BNP Paribas Arbitrage SNC	202,310	$5.59M	0.0%	-14.9%	0.352%
8/9/2023	TD Asset Management Inc	55,400	$1.53M	0.0%	+91.0%	0.096%
8/9/2023	Swiss National Bank	98,000	$2.71M	0.0%	+23.0%	0.170%

Data available starting January 2016

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Today's Range

Now: $25.15

$24.22

$25.23

50 Day Range

MA: $28.31

$24.66

$32.15

52 Week Range

Now: $25.15

$13.72

$33.34

Volume

461,248 shs

Average Volume

691,328 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01

Who are the company insiders with the largest holdings of Protagonist Therapeutics?: Protagonist Therapeutics' top insider investors include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More about top insider investors at Protagonist Therapeutics.
Who are the major institutional investors of Protagonist Therapeutics?: Protagonist Therapeutics' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.06%
Los Angeles Capital Management LLC — 0.05%
Allspring Global Investments Holdings LLC — 0.00%
Learn More about top institutional investors of Protagonist Therapeutics stock.
Which major investors are selling Protagonist Therapeutics stock?: Within the previous quarter, PTGX stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
During the previous year, company insiders that have sold Protagonist Therapeutics company stock include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More investors selling Protagonist Therapeutics stock.
Which major investors are buying Protagonist Therapeutics stock?: Within the last quarter, PTGX stock was bought by institutional investors including:
Los Angeles Capital Management LLC
Hennion & Walsh Asset Management Inc.